Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb;4(2):20-7.

An update on nonmelanoma skin cancer

Rita V Patel  1 , Amylynne Frankel, Gary Goldenberg
Affiliations

An update on nonmelanoma skin cancer

Rita V Patel et al. J Clin Aesthet Dermatol. 2011 Feb.

Abstract

Estimates from the American Cancer Society suggest that there are more than two million cases of nonmelanoma skin cancer in the United States per year. The following review highlights the topics of actinic keratoses, basal cell carcinoma, squamous cell carcinoma, Kaposi's sarcoma, and Merkel cell carcinoma. This update on the cutting-edge clinical and dermpathologic research will assist the dermatologist in approaching, diagnosing, and managing nonmelanoma skin carcinoma. Immunologic and genetic research into nonmelanoma skin carcinoma has paved the way for novel therapeutic options for patients who were previously without any viable treatment alternatives. While still in preliminary stages, agents, such as ingenol mebutate, vismodegib, and sirolumus, may become integral drugs in the armamentarium of managing cutaneous carcinoma.

PubMed Disclaimer

References

    1. Skin Cancer Facts. [04/30/2010]. http://www.cancer.org/Cancer/CancerCauses/SunandUVExposure/skin-cancer-f....
    1. Long CC, Marks R. Increased risk of skin cancer: another Celtic myth? A review of Celtic ancestry and other risk factors for malignant melanoma and nonmelanoma skin cancer. J Am Acad Dermatol. 1995;33(4):658–661. - PubMed
    1. Goldberg L. Review of actinic keratosis. Part 1: etiology, epidemiology and clinical presentation. J Drug Dermatol. 2010;9:1125–1132. - PubMed
    1. Stockfleth E, Ferrandiz C, Grob JJ, et al. Development of a treatment algorithm for actinic keratoses: a European consensus. Eur J Dermatol. 2008;18(6):651–659. - PubMed
    1. Anderson L, Schmieder GJ, Werschler WP, et al. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis. J Am Acad Dermatol. 2009;60(6):934–943. - PubMed

LinkOut - more resources